Skip to main content
profile image
Selected Works of Achal Achrol, MD
Article
ATIM-05. INTRATUMORAL DELIVERY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, BY MRI-GUIDED CONVECTIVE DELIVERY FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA
Neuro-oncology (2018)
  • Achal Achrol, John Wayne Cancer Institute and Pacific Neuroscience Institute, Santa Monica, CA, USA
  • Martin Bexon, Medicenna Biopharma, Houston, TX, USA
  • Krystof Bankiewicz, University of California, San Francisco
  • Andrew J Brenner, Mays Cancer Center/ UT Health San Antonio, San Antonio, TX, USA
  • Nicholas Butowski, University of California, San Francisco
  • Santosh Kesari, John Wayne Cancer Institute and Pacific Neuroscience Institute, Santa Monica, CA, USA
  • Fahar Merchant, Medicenna Biopharma, Houston, TX, USA
  • Rosemina Merchant, Medicenna Biopharma, Houston, TX, USA
  • Dina Randazzo, Duke University
  • Michael Vogelbaum, Cleveland Clinic
  • Miroslaw Zabek, Mazovian Brodnowski Hospital, Warsaw, Mazowieckie, Pol
  • John Sampson, Duke University
Link
Disciplines
Publication Date
November 5, 2018
DOI
10.1093/neuonc/noy148.002
Citation Information
Achal Achrol, Martin Bexon, Krystof Bankiewicz, Andrew J Brenner, et al.. "ATIM-05. INTRATUMORAL DELIVERY OF MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, BY MRI-GUIDED CONVECTIVE DELIVERY FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA" Neuro-oncology Vol. 20 (2018)
Available at: http://works.bepress.com/achalsingh-achrol/5/